A Study of Subcutaneous (SC) Tocilizumab (RoActemra/Actemra) in Participants With Active Rheumatoid Arthritis (RA) and Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
Clinical trial NCT02046616 · COMPLETED
Trial details
- NCT number
- NCT02046616
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-28
- Primary completion
- 2016-09-13
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.